1-(3-Methoxybenzyl)cyclobutanamine hydrochloride, 1g

3-Fluoro-4-morpholin-aniline, 97.0%, 1g

Cyclohexane, min. 99.5%, for synthesis, 5 l, alu

TAMSULOSIN, 97%, 25mg

[(1R)-1-[[(2S,3R)-3-Hydroxy-2-[[(6-phenylpyridin-2-yl)carbonyl]amino]-1-oxobutyl]amino]-3-methylbutyl]boronic acid, 97%, 5mg

N-[(1S,2S)-2-({2-[(2-methylpropane-2-sulfinyl)amino]-3,4-dioxocyclobut-1-en-1-yl}amino)-1,2-diphenylethyl]-3,5-bis(trifluoromethyl)benzamide, 96.28%, 100mg

ROTI®ContiPlate TSA

(Z)-4-(cyclohexylamino)-4-oxobut-2-enoic acid, 97%, 5g

4-Bromo-2,6-difluorobenzenesulfonyl chloride, 250mg

7-Nitro-4-(pyridin-2-ylmethyl)-2H-benzo[b][1,4]oxazin-3(4H)-one, 95+%, 100mg

Methyl Quinoline-5-carboxylate, 95.0%, 5g

2-[(2-methylphenoxy)methyl]-1H-benzimidazole, 95.0%, 250mg

L-Glutamic acid, 500 g